{
  "docId": "019de075-3207-70ec-93a8-5bb5ec3d9629",
  "docSlug": "951aacbbe982699d0f743a597a954ece",
  "documentTitle": "OKYO Pharma | Results Presentation Deck | 25 slides",
  "authorId": "okyo-pharma",
  "authorName": "OKYO Pharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 25,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "timeline",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3207-70ec-93a8-5bb5ec3d9629/19",
  "deckHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629",
  "deckJsonHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629.json",
  "deckAnchorHref": "/decks/019de075-3207-70ec-93a8-5bb5ec3d9629#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.76,
        "x": 0.12,
        "y": 0.42
      },
      "kind": "diagram",
      "text": null,
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8eceeb9b-44b1-4db4-82c0-77a9720bb437",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.1,
        "x": 0.64,
        "y": 0.64
      },
      "kind": "image",
      "text": "CRO Partner Ora",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3bd68d06-e308-4c71-8461-a091b48ec168",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.29,
        "y": 0.18
      },
      "kind": "list",
      "text": "Phase 2: 240 subjects/ 80 per arm, 12 Week Dosing, 6-8 months Duration, Potential Registration Trial",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4e65039-f610-4e76-b4fe-a3c5ac78557c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.15,
        "x": 0.22,
        "y": 0.64
      },
      "kind": "paragraph",
      "text": "Trial Start Announced on May 2, 2023",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23d3cd35-abb2-433a-8e84-176ff64a7019",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.15,
        "x": 0.42,
        "y": 0.64
      },
      "kind": "paragraph",
      "text": "Anticipated Phase 2 Top-Line Data",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93eff56b-65e1-4125-8304-8fff978b88e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "OK-101 Development Timeline",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "582e8c2a-1ee3-4825-ba62-ccc85ae50768",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "9a15bd57-cfc8-464e-acef-f6a51c342b94",
      "evidence": "The slide uses a horizontal timeline to represent project phases and milestones.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}